---
title: "P/E Ratio Insights for Intuitive Surgical"
description: "Intuitive Surgical Inc. (NASDAQ:ISRG) shares rose 2.33% to $465.11, but have decreased by 1.06% over the past month and 2.98% over the past year. The company's P/E ratio stands at 63.39, higher than t"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256172820.md"
published_at: "2025-09-05T17:00:32.000Z"
---

# P/E Ratio Insights for Intuitive Surgical

> Intuitive Surgical Inc. (NASDAQ:ISRG) shares rose 2.33% to $465.11, but have decreased by 1.06% over the past month and 2.98% over the past year. The company's P/E ratio stands at 63.39, higher than the industry average of 47.52, suggesting potential overvaluation despite better performance expectations. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative factors for informed decision-making.

In the current market session, **Intuitive Surgical Inc. (NASDAQ:ISRG)** price is at $465.11, after a **2.33%** increase. However, over the past month, the stock decreased by **1.06%**, and in the past year, by **2.98%**. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session.

![Past Year Chart](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1757091629_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

### How Does Intuitive Surgical P/E Compare to Other Companies?

The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued.

Intuitive Surgical has a better P/E ratio of **63.39** than the aggregate P/E ratio of **47.52** of the Health Care Equipment & Supplies industry. Ideally, one might believe that Intuitive Surgical Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued.

![Guage](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1757091629_1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

### Related Stocks

- [ISRG.US - Intuitive Surgical](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 直覺外科｜10-K：2025 財年營收 101 億美元超過預期 |  | [Link](https://longbridge.com/en/news/274719864.md) |
| 直覺外科：DV5 的採用、創新研發管道以及強勁的增長前景支持其高估值的買入評級 | 威廉·布萊爾分析師布蘭登·瓦茲奎茲對直覺外科（ISRG）股票維持 “買入” 評級，理由是其強勁的運營勢頭和戰略定位。初步的 2025 年業績顯示系統安裝和收入超出預期，這得益於 DV5 平台的採用。儘管對 2026 年的手術指導較為保守，瓦 | [Link](https://longbridge.com/en/news/272600700.md) |
| 直覺外科的收益預覽：我們可以期待什麼 | 直覺外科財報預覽：我們可以期待什麼 | [Link](https://longbridge.com/en/news/270598562.md) |
| 20 年前投資 100 美元在直覺外科公司，今天會值這麼多 | 直覺外科 (NASDAQ:ISRG) 在過去 20 年中實現了平均年回報率 20.44%，超出市場 11.68%。目前市值為 2006.4 億美元，20 年前對 ISRG 股票的 100 美元投資現在價值為 4041.87 美元，突顯了複利 | [Link](https://longbridge.com/en/news/271673917.md) |
| Synektik 擴大並延長了與直覺外科的分銷協議 | Synektik SA：與直覺外科延長分銷協議，涵蓋烏克蘭，並將合作期限延長至 2031 年 12 月 31 日 | [Link](https://longbridge.com/en/news/274476098.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.